VERSAPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Versapen, and when can generic versions of Versapen launch?
Versapen is a drug marketed by Bristol and is included in three NDAs.
The generic ingredient in VERSAPEN is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.
Summary for VERSAPEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 3,275 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VERSAPEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VERSAPEN
US Patents and Regulatory Information for VERSAPEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | VERSAPEN | hetacillin | FOR SUSPENSION;ORAL | 061398-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN | hetacillin | FOR SUSPENSION;ORAL | 061398-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN | hetacillin | FOR SUSPENSION;ORAL | 050060-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN | hetacillin | FOR SUSPENSION;ORAL | 050060-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN-K | hetacillin potassium | CAPSULE;ORAL | 061396-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN-K | hetacillin potassium | CAPSULE;ORAL | 061396-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |